An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
Data up to Jan 2025
Total Citations Per Year
Abstract
References (51)
TGF-β signaling in tumor suppression and cancer progression
2001 • 2,235 citations
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 • 2,075 citations
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
1993 • 1,941 citations
Sea Anemone Genome Reveals Ancestral Eumetazoan Gene Repertoire and Genomic Organization
2007 • 1,556 citations
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
2004 • 1,346 citations
Roles of the NKG2D immunoreceptor and its ligands
2003 • 1,297 citations
TGFβ: the molecular Jekyll and Hyde of cancer
2006 • 1,228 citations
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.
1992 • 1,217 citations
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease
2000 • 970 citations
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
2001 • 759 citations
Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance
2003 • 539 citations
Development of TGF-β signalling inhibitors for cancer therapy
2004 • 536 citations
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
2006 • 520 citations
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients
2004 • 518 citations
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
2002 • 490 citations
Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β
2007 • 438 citations
Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis
2003 • 433 citations
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
2007 • 425 citations
SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma CellsIn vitroandIn vivo
2004 • 407 citations
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
2002 • 406 citations
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling
2007 • 397 citations
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
2002 • 375 citations
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
1993 • 356 citations
Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis
2005 • 336 citations
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
2002 • 326 citations
The role for transforming growth factor-beta (TGF-beta) in human cancer.
1999 • 323 citations
Smad4 signalling in T cells is required for suppression of gastrointestinal cancer
2006 • 314 citations
Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification.
1989 • 307 citations
RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates TumorigenicityIn vivo
2004 • 288 citations
Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17
2008 • 232 citations
Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low‐dose γ‐irradiation 1
1997 • 227 citations
Dual role for TGF-?1 in apoptosis
2005 • 215 citations
Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
1993 • 181 citations
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer.
1995 • 159 citations
Transforming Growth Factor-β and the Immune Response to Malignant Disease
2007 • 158 citations
Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor KinaseIn vivo
2006 • 149 citations
Adoptive Transfer of Tumor-Reactive Transforming Growth Factor-β–Insensitive CD8+ T Cells: Eradication of Autologous Mouse Prostate Cancer
2005 • 147 citations
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
2002 • 144 citations
TGF Beta Inhibition for Cancer Therapy
2006 • 118 citations
A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection
2007 • 110 citations
Bone Sialoprotein Mediates the Tumor Cell–Targeted Prometastatic Activity of Transforming Growth Factor β in a Mouse Model of Breast Cancer
2006 • 88 citations
Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
1999 • 77 citations
Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
2004 • 65 citations
Blockade of transforming growth factor-β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle
2006 • 54 citations
Minimal Effects on Immune Parameters Following Chronic Anti-TGF-β Monoclonal Antibody Administration to Normal Mice
2003 • 53 citations
Reconstitution of Lethally Irradiated Adult Mice with Dominant Negative TGF-β Type II Receptor-Transduced Bone Marrow Leads to Myeloid Expansion and Inflammatory Disease
2002 • 40 citations
Specific and sensitive quantitation of transforming growth factor β3 by sandwich enzyme-linked immunosorbent assay
1995 • 26 citations
Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo
2003 • 25 citations
Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice
2007 • 16 citations
Plasma transforming growth factor beta levels in breast cancer patients.
1998 • 13 citations
VEGF Inhibition for Cancer Therapy
2007 • 3 citations
Cited By (0)
No citing papers found in database